Abstract-Characterisation of the pharmacological pro le of non-physiological amine oxidase substrates could help to identify the endogenous role of this class of enzymes. Previous studies have suggested that benzylamine, a common non-physiological substrate for monoamine and tissue-bound or soluble benzylamine oxidases, could behave as a potassium channel blocking agent. Potassium channel blockers are known to modify several forms of animal behaviour including food consumption. To characterise further the pharmacological pro le of benzylamine and the role of amine oxidases, we have studied the effect of benzylamine on mice food intake. Our results con rm that benzylamine produces a reduction in mice feeding in a similar manner to that obtained by amphetamine. The anorectic effect of benzylamine and amphetamine in mice was potentiated by pretreatment with amine oxidase inhibitors. In addition, the introduction of substituents in the aromatic ring of benzylamine did not produce compounds with a higher anorectic potency than the one measured with benzylamine.
INTRODUCTION
Several forms of animal behaviour are modulated by primary amines, which act, in the central nervous system, as neurotransmitters. For each of these primary amines, the enzymatic systems involved in their synthesis and metabolism are located close to the site of their release. Amine concentrations at the synaptic cleft can be modulated pharmacologically by the use of precursors of their biosynthetic pathways, inhibitors of their metabolism or agents able to induce amine release from the endogenous storage sites. Among these, the role of monoamine oxidase inhibitors (MAOIs) and that of potassium channel blockers as modulator of neurotransmitter turnover or release have been studied extensively (Knoll, 1998; Schechter, 1997) . As a consequence of their mechanisms of action, MAOIs and potassium channel blockers have been used to study the control of different forms of animal behaviour.
For example, feeding is one form of animal behaviour affected by changes in the central concentrations of some amines (Shucla et al., 1990) . In addition, potassium channel blockers can also modify food intake (Ghelardini et al., 1997) .
Benzylamine (Bz) is a simple primary aromatic amine which is a good substrate for MAO-B and tissue-bound benzylamine oxidase (Bz-SSAO), two amine oxidases with different tissue and subcellular localisation. Benzylamine degradation by both classes of enzymes produces hydrogen peroxide, a compound capable of regulating glucose uptake in adipocytes (Tarancon et al., 1999) . However, we have collected evidence that Bz itself could have its own pharmacological pro le. In particular, we veri ed that Bz shares several forms of behaviour typical of potassium channelblockers Banchelli et al., 1999) . These two charcateristics, the regulation of glucose homeostasis and the block of potassium channels, could be of interest in animal experimental models of metabolic diseases which are also characterised by changes in amine oxidase activity (Meszaros et al., 1999) The effects of Bz and of other related compounds on mice feeding behaviour has been studied in relation to the effects of inhibition of its metabolism by amine oxidases to determine if any correlation exists between the effect of the different amines on food intake in mice and their metabolism by amine oxidases.
The effect of Bz and of other related amines on mice feeding behaviour was evaluated and compared with the effects of tetraethylammonium (TEA), known to block voltage-gated potassium channels, and amphetamine (AMPH), an indirectly acting sympathomimetic amine which causes anorexia in mice.
MATERIALS AND METHODS

Drugs
Deprenyl (selegiline) hydrochloride, clorgyline, benzylamine, tetraethylammonium hydrochloride, amphetamine sulphate and ®-methyl-p-tyrosine were purchased from Sigma (St. Louis, MO, USA).
[7-14 C]Benzylamine hydrochloride (57 mCi/mmol) and 5-hydroxy[2-14 C]tryptamine (50 mCi/mmol) were obtained from Amersham Pharmacia Biotech Italia (Milan, Italy). MDL 72274 was a gift from the Marion Merrel Dow Research Institute (Strasbourg, France). Drugs were dissolved in isotonic saline solution (NaCl 0.9%); drug concentrations were prepared in such a way that the necessary dose could be administered in a volume of 5 ¹l/ mouse (i.c.v. injection) and 10 ml/kg (i.p. injection).
Animals
Male Swiss albino mice (23-30 g) from the Morini (San Polo d'Enza, Italy) breeding farm were used. Fifteen mice were housed per cage. The cages were placed in the experimental room 24 h before the test for adaptation. The animals were kept at 23 § 1 ± C with a 12 h light-dark cycle, light on at 7.00 a.m., and fed a standard laboratory diet and water ad libitum. All experiments were carried out in accordance with the European Communities Council Directive of 24 November 1986 (86/ 609/ EEC) for experimental animal care.
Intracerebroventricular injection
Intracerebroventricular (i.c.v.) administration was performed under ether anesthesia, according to the method described by Haley and McCormick (1957) . Drugs (5 ¹l) were injected randomly into the right or left ventricle.
Evaluation of food consumption
Before testing, mice were deprived of access to food for 12 h, but water was available ad libitum. A weighed amount of food (standard laboratory pellets) was given, and the weight consumed (evaluated as the difference between the original amount and the food left in the cage, including spillage), was measured 15, 30, 45 and 60 min after injection, with an accuracy of 0.1 g. An arbitrary cut-off time of 60 min was used. Amine oxidase inhibitors or ®-methyl-p tyrosine were administered to mice i.p. 1 h and 2 h, respectively, before treatment with Bz, AMPH and TEA or Bz derivatives.
Hole-board test
The hole-board test set up consisted of a 40-cm square plane with 16 ush-mounted cylindrical holes (diameter 3 cm) distributed 4 by 4 in an equidistant, grid-like manner. Mice were placed on the center of the board one by one, and were left to move about freely for a period of 5 min each. Two photoelectric beams, crossing the plane from mid-point to mid-point of opposite sides, thus dividing the plane into 4 equal quadrants, automatically signaled the movement of the animals on the surface of the plane. Miniature photoelectric cells, in each of the 16 holes, recorded the exploration of the holes (head plunging activity) by the mice. The test was performed 60 min after i.c.v. administration of TEA, BZ or AMPH.
Amine oxidase activity
Rat white adipocytes and mice liver mithocondria were chosen as sources for Bz-SSAO and MAO type B activities, respectively.
Rat white adipocytes were prepared by collagenase digestion according to Rodbel (1964) and Bz-SSAO activity was measured according to Raimondi et al. (1993), using [ 14 C]benzylamine (from 2.5 to 25 ¹M) as substrate. Mice livers were homogenised (1:10) using 10 mM sodium-potassium phosphate buffer pH 7.4 (phosphate buffer), and centrifuged at 1000 g at 4 ± C. The resulting supernatant was spun again at 9000 g for 10 min at the same temperature. The mitocondrial pellet was washed twice by centrifugation and re-suspended in phosphate buffer. Monoamine oxidase activity was measured radiochemically using [ 14 C]benzylamine (from 25 to 500 ¹M) as substrate. Labelled substrate oxidation was followed for 30 min at 37 ± C and metabolites, extracted with ethylacethate, were counted in a¯-counter machine.
RESULTS AND DISCUSION
A signi cant reduction of food consumption was found in mice treated i.c.v. with Bz (226 nmol), TEA (30 nmol) and AMPH (5 nmol) ( Table 1) .
The anorectic effect of all the drugs examined was potentiated by pretreating mice with deprenyl (10 mg/ kg i.p.) a selective MAO-B inhibitor. In contrast, clorgyline (2.5 mg/kg i.p.) pre-treatment potentiated only Bz and AMPH hypophagia, leaving that of TEA unaffected. These results suggested that the reduction of food intake produced by the drugs tested was related to release of amines which are good substrates for MAO, the predominant amine oxidase activities in the mouse brain.
Bz-induced reduction of food intake seemed to resemble more closely that produced by AMPH than that produced by TEA. We hypothesise that both amines could release neurotransmitters involved in feeding behaviour, such as dopamine and serotonin, which are known to be endogenous substrates for MAO B and A, respectively.
When Bz was given i.p. it was necessary to inhibit MAO B and Bz-SSAO activities in order to unmask its anorectic effect. This latter result suggests that the inhibition of Bz metabolic pathways is crucial for the detection of a central effect of Bz.
To ascertain whether or not Bz was able to show an amphetamine-like effect on mice locomotor activity, we carried out the hole-board test using mice treated with both Bz and AMPH (Table 2) . From our results, AMPH could increase the locomotor activity of mice by stimulating both the number of limb movements and the number of times the mice plunged their heads into the holes. The stimulating effect of AMPH was inhibited in mice pre-treated with ®-methyl-p-tyrosine to 
®-Mpt (100 mg/kg i.p.) was administered 2 h before Bz (226 nmol) and AMPH (5 nmol) treatment of mice as described in Section 2. Results are the mean § S.E. of the measurements obtained from 15-30 mice. ¤ Signi cantly different versus saline-treated mice (P < 0:01, Student's t -test for grouped data). Table 3 . The anorectic effect of benzylamine and related amines and their apparent kinetic constants for amine oxidases reduce endogenous stores of amine neurotransmitters. This result is consistent with the effect of AMPH being to cause dopamine release. In contrast, anorectic doses of Bz did not increase locomotor activity of mice. Similarly, in mice pre-treated with deprenyl, Bz in anorectic doses had no action on locomotor activity (data not shown).
These results strongly suggest that, unlike AMPH, the anorexia produced by Bz is not associated with any general stimulation of the central nervous system. Thus, having ascertained that Bz produced this effect on mouse behaviour, we treated mice with a series of Bz derivatives in order to see if some sort of correlation between the anorectic effect and their potency as amine oxidase substrates existed. Table 3 reports the hypophagic effect produced by Bz and by some Bz derivatives (given i.c.v.) and their kinetic constants as substrates for MAO B and Bz-SSAO.
Among the Bz-halogen derivatives, the introduction of a Br ¡ or CH 3 residue in the meta-or para-position on benzylamine moiety shifted K m for MAO-B oxidation towards lower values, leaving the kinetic constants for Bz-SSAO deamination almost anaffected. However, the modi cation of kinetic constants did not produce any effects on food consumption. This suggests a lack of correlation between the af nity of Bz-derivatives for amine oxidases and their anorectic effect. Thus, Bz remains the best chemical structure among those tested, able to cause anorexia in mice.
However, it is clear from our results that, following the i.p. administration of Bz, the amine oxidase activities in peripheral tissues are important in determining the concentrations of this amine in the central nervous system. This nding should be taken into account when pharmacological approaches with amine oxidase substrates are carried out. In this respect, the availability of more selective inhibitors of amine oxidase activities would help to clarify the role of these enzymes in the modulation of their substrate-induced effects.
